Europe Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis Report 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Europe Chronic Obstructive Pulmonary Disease Epidemiology and Patient Flow Analysis - 2017" report to their offering.

The report provides insights into Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease diagnosed patients, and Chronic Obstructive Pulmonary Disease treatment rate for EU5 pharmaceutical markets.

The study measures key indicators such as prevalence of Chronic Obstructive Pulmonary Disease derived from epidemiological analysis, percentage of patients diagnosed with Chronic Obstructive Pulmonary Disease, and percentage of patients treated with a therapy.

The study helps executives estimate Chronic Obstructive Pulmonary Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Chronic Obstructive Pulmonary Disease prevalence, Chronic Obstructive Pulmonary Disease diagnosis rate, and Chronic Obstructive Pulmonary Disease treatment rate for the period 2016 - 2025.

Key Features of the Report:

  • Chronic Obstructive Pulmonary Disease Patient Flow
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Chronic Obstructive Pulmonary Disease Diagnosed Patients
  • Chronic Obstructive Pulmonary Disease Treated Patients

Key Topics Covered:

1. Chronic Obstructive Pulmonary Disease: Disease Definition

2. Chronic Obstructive Pulmonary Disease Patient Flow in Europe

3. Chronic Obstructive Pulmonary Disease Patient Flow in Germany

4. Chronic Obstructive Pulmonary Disease Patient Flow in France

5. Chronic Obstructive Pulmonary Disease Patient Flow in Spain

6. Chronic Obstructive Pulmonary Disease Patient Flow in Italy

7. Chronic Obstructive Pulmonary Disease Patient Flow in UK

For more information about this report visit http://www.researchandmarkets.com/research/q2sxx5/europe_chronic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs